Achilleas - New Portfolio
Achilleas
AchilleasIndividual Investor
Ranked #459,945 out of 858,885 TipRanks' Investors
Success Rate
55 out of 137
profitable transactions
profitable transactions
Average Return
18.68%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 0.63%
6-Month Return▲ 9.25%
12-Month Return▲ 70.13%
YTD Return▲ 1.21%
Total Return▲ 123.02%
Best Trade
Bio
Amateur trialing for some growth.
Performance
12.88%0-12.88%
▲ 12.88%
▲ 3.56%
▲ 6.40%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 2.98%
Oct 2025
▼ 3.68%
▲ 0.19%
▼ 0.30%
Nov 2025
▼ 0.10%
▲ 0.08%
▲ 8.02%
Dec 2025
▲ 4.06%
▲ 1.47%
▼ 1.77%
Jan 2026
▼ 1.12%
▼ 0.86%
▲ 6.36%
Feb 2026
▲ 0.60%
▼ 4.94%
▼ 5.81%
Mar 2026
▲ 4.89%
▲ 4.48%
▲ 2.84%
Apr 2026
▲ 12.88%▲ 3.56%▲ 6.40%
▲ 10.96%▲ 2.38%▲ 2.98%
▼ 3.68%▲ 0.19%▼ 0.30%
▼ 0.10%▲ 0.08%▲ 8.02%
▲ 4.06%▲ 1.47%▼ 1.77%
▼ 1.12%▼ 0.86%▲ 6.36%
▲ 0.60%▼ 4.94%▼ 5.81%
▲ 4.89%▲ 4.48%▲ 2.84%
Recent Activity
Dynavax
―
▲ 162.09%
6
Close
Feb 09, 2026
Lazydays Holdings
―
▼ 99.93%
2
Close
Nov 28, 2025
Dun & Bradstreet Holdings
―
▼ 62.71%
2
Close
Aug 25, 2025
Revance Therapeutics
―
▼ 85.68%
2
Close
Feb 05, 2025
VBI Vaccines
―
▼ 35.13%
6
Close
Jan 13, 2025
SurgePays
0%
▼ 76.98%
1
Open
Jul 03, 2024
CymaBay Therapeutics
―
▲ 792.03%
4
Close
Mar 25, 2024
Textainer Group Holdings
―
▲ 147.10%
2
Close
Mar 14, 2024
Harpoon Therapeutics
―
▼ 76.42%
2
Close
Mar 08, 2024
Orchard Therapeutics
―
▼ 68.67%
4
Close
Jan 24, 2024
Kaleyra
―
▼ 47.89%
3
Close
Oct 04, 2023
Syneos Health
―
▼ 37.76%
2
Close
Sep 27, 2023
Prometheus Biosciences
―
▲ 772.63%
2
Close
Jun 15, 2023
Otonomy
―
▼ 97.36%
2
Close
Apr 11, 2023
ClearSign Combustion
―
▼ 86.37%
2
Close
Apr 02, 2023
Switch
―
▲ 104.10%
2
Close
Dec 06, 2022
Epizyme
―
▼ 90.48%
4
Close
Aug 11, 2022
Arbor Realty
0%
▼ 22.51%
1
Open
Jul 22, 2022
Twilio
0.12%
▲ 37.91%
1
Open
Jul 18, 2022
Exxon Mobil
0.16%
▲ 101.22%
1
Open
Jul 18, 2022